ArticleCase reports in neurological medicine2025
Acyclovir Encephalopathy in HSV Encephalitis Elderly With Normal Renal Function.
Article in Case reports in neurological medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Herpes simplex virus (HSV) encephalitis is a disease treated with acyclovir (ACV). However, the neurotoxicity of ACV can lead to the development of ACV encephalopathy. While ACV is used to treat HSV encephalitis, the treatment for ACV encephalopathy is to discontinue the use of ACV. Electroencephalography (EEG) is useful for distinguishing ACV encephalopathy from HSV encephalitis. An 83-year-old male presented with fever and fatigue. He had no decline of renal function. By the fourth day, he experienced tonic-clonic seizures, right-sided conjugate deviation, and loss of consciousness, leading to a diagnosis of HSV encephalitis. He was treated with ACV, which resulted in acute kidney injury (AKI) and loss of consciousness. A diagnosis of ACV encephalopathy with AKI was confirmed by EEG. His treatment continued by vidarabine instead of ACV. His AKI improved after discontinuing ACV and performing plasma exchange, and his level of consciousness fully returned to normal. This case highlights the utility of EEG for distinguishing HSV encephalitis from ACV encephalopathy. We conducted the literature review, and AKI is considered as a risk factor for ACV encephalopathy in elderly patient using ACV or valacyclovir. However, we could not identify a cause for AKI in our case apart from the use of ACV.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.